Highlights
1 patent
About
Robotic Endoscopic Suturing
Nitinotes is a clinical-stage company developing a revolutionary treatment for obesity. Its flagship product, the EndoZip, simplifies and speeds up endoscopic gastroplasty procedures, offering a widely available, minimally invasive, and effective solution for over 700 million patients with obesity class I & II for whom traditional bariatric surgery is not an option.
EndoZip is an automated and operator-independent, minimally invasive robotic suturing system, for safe and easy delivery of effective restrictive sutures to the stomach wall.
Nitinotes is conducting a series of pilot studies in various sites around the world aimed at fortifying both its clinical and economic cases.
Identity
| Name | NitiNotes |
|---|---|
| Slug | nitinotes |
| Type / kind | startup |
| Crunchbase ID | nitiniotes |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICAgMG2wYEJDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | Center District |
| HQ city | Caesarea |
| HQ address | HaEshel Street 5, Caesarea, Israel |
Web & social
| Website | https://nitinotesurgical.com |
|---|---|
| https://www.linkedin.com/company/33244041 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Technologies
Machinery & Robotics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business models
B2B
Tags
roboticsobesitynon-surgicalgastroenterologyminimally-invasiveendoscopysurgeonshospitalsmedical-devicesdoctorsclinicstreatments
Funding
| Total raised | $32.9M |
|---|---|
| Current stage | Series B |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}